- Home
- TARS vs GBX Comparison
TARS vs GBX Comparison
Compare TARS & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- GBX
- Stock Information
- Founded
- TARS 2016
- GBX 1974
- Country
- TARS United States
- GBX United States
- Employees
- TARS N/A
- GBX N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- GBX Railroads
- Sector
- TARS Health Care
- GBX Industrials
- Exchange
- TARS Nasdaq
- GBX Nasdaq
- Market Cap
- TARS 1.8B
- GBX 1.6B
- IPO Year
- TARS 2020
- GBX N/A
- Fundamental
- Price
- TARS $44.83
- GBX $65.08
- Analyst Decision
- TARS Strong Buy
- GBX Hold
- Analyst Count
- TARS 5
- GBX 3
- Target Price
- TARS $54.20
- GBX $60.00
- AVG Volume (30 Days)
- TARS 1.1M
- GBX 399.1K
- Earning Date
- TARS 11-13-2024
- GBX 01-03-2025
- Dividend Yield
- TARS N/A
- GBX 1.84%
- EPS Growth
- TARS N/A
- GBX 163.31
- EPS
- TARS N/A
- GBX 4.96
- Revenue
- TARS $129,621,000.00
- GBX $3,544,700,000.00
- Revenue This Year
- TARS $852.60
- GBX $1.11
- Revenue Next Year
- TARS $74.21
- GBX N/A
- P/E Ratio
- TARS N/A
- GBX $13.12
- Revenue Growth
- TARS 801.96
- GBX N/A
- 52 Week Low
- TARS $15.60
- GBX $36.23
- 52 Week High
- TARS $52.99
- GBX $67.22
- Technical
- Relative Strength Index (RSI)
- TARS 57.98
- GBX 77.98
- Support Level
- TARS $46.22
- GBX $64.82
- Resistance Level
- TARS $52.99
- GBX $67.22
- Average True Range (ATR)
- TARS 3.62
- GBX 1.41
- MACD
- TARS -0.33
- GBX 0.24
- Stochastic Oscillator
- TARS 42.09
- GBX 93.67
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of revenue from the United States.